Galera Therapeutics Inc (GRTX): i was thinking the same thing just befor...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	82
Boards Moderated	0
Alias Born	01/18/2017

ah86

Re: Pedro2004 post# 77

Tuesday, 12/14/2021 2:19:20 PM

Tuesday, December 14, 2021 2:19:20 PM

i was thinking the same thing just before i read your message. 11M public float. and the volume is 230M+
Daaayuum!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent GRTX News

Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 11:02:02 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:00:54 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 02:26:45 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 05/16/2024 02:26:17 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/16/2024 02:25:53 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 11:30:28 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:05:31 AM
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates • GlobeNewswire Inc. • 05/13/2024 11:00:00 AM
Galera Adopts Limited Duration Stockholder Rights Agreement • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:06:04 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/20/2024 11:57:58 PM
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates • GlobeNewswire Inc. • 11/14/2023 12:00:00 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/13/2023 07:24:56 PM
Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial • Dow Jones News • 10/31/2023 12:09:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 11:10:53 AM
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update • GlobeNewswire Inc. • 10/31/2023 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 11:24:59 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 09:12:53 PM
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem • GlobeNewswire Inc. • 09/18/2023 11:00:00 AM
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/05/2023 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:36 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:10:28 AM
Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates • GlobeNewswire Inc. • 08/14/2023 11:00:17 AM

More GRTX News

InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover